Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2001 Aug;46(8):1787-90.
doi: 10.1023/a:1010682310928.

Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis

D A Schwartz  1 , D S Pardi, J A Murray
Affiliations
Case Reports

Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis

D A Schwartz et al. Dig Dis Sci. 2001 Aug.

Abstract

Patients with eosinophilic gastroenteritis generally respond well to corticosteroids but relapses are common. Patients with relapsing disease are usually placed on long-term low-dose prednisone or immunosuppressive therapy. Here we reported on a patient with severe steroid-dependent eosinophilic gastroenteritis who was able to successfully taper off steroids and maintain remission after starting montelukast, a leukotriene receptor antagonist. To our knowledge, this is the first use of montelukast as a steroid sparing agent for eosinophilic gastroenteritis.

PubMed Disclaimer

References

    1. Eur J Gastroenterol Hepatol. 1997 May;9(5):533-7 - PubMed
    1. J Leukoc Biol. 1994 Feb;55(2):183-91 - PubMed
    1. Neth J Med. 1999 May;54(5):197-201 - PubMed
    1. Mayo Clin Proc. 1994 May;69(5):441-4 - PubMed
    1. Eur J Surg. 1992 Jan;158(1):63-4 - PubMed

Publication types